Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2025 FYStats. 
Home
Equities
TNFA
Chart

Tnf Pharmaceuticals, Inc.

TNFA

Jan 1 1970 00:00:00
0.00
0.000.00%
0.00
0.00
0.00
0.00
0.00
-2.01
176.62M
Chart
Fundamentals
Soon
Sentiment
Soon
Options
Loading...

Recent Filings

2024-11-01
Form ARS
ID: 0001493152-24-043340
2024-11-01
Form DEF 14A
ID: 0001493152-24-043339
2024-10-07
Form 8-K
ID: 0001493152-24-040276
2024-10-04
Form 8-K
ID: 0001493152-24-039556
2024-09-23
Form 8-K
ID: 0001493152-24-037819
2024-08-19
Form 10-Q
ID: 0001493152-24-032940
2024-08-14
Form NT 10-Q
ID: 0001493152-24-032276
2024-08-14
Form 8-K
ID: 0001493152-24-032169
2024-08-12
EFFECT
ID: 9999999995-24-002498
2024-08-12
Form 424B3
ID: 0001493152-24-031347

You might find these companies interesting

NYMXF
Nymox Pharmaceutical Corp
In Vitro & In Vivo Diagnostic Substances (2835)
NTLA
Intellia Therapeutics, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
IDXX
Idexx Laboratories Inc /De
In Vitro & In Vivo Diagnostic Substances (2835)
BMRA
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances (2835)
TRIB
Trinity Biotech Plc
In Vitro & In Vivo Diagnostic Substances (2835)
QDEL
Quidelortho Corp
In Vitro & In Vivo Diagnostic Substances (2835)
TKNO
Alpha Teknova, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
MYGN
Myriad Genetics Inc
In Vitro & In Vivo Diagnostic Substances (2835)
CLDX
Celldex Therapeutics, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
CDIO
Cardio Diagnostics Holdings, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
ABIO
Arca Biopharma, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
OCX
Oncocyte Corp
In Vitro & In Vivo Diagnostic Substances (2835)
REPCF
Replicel Life Sciences Inc.
Biological Products, (No Diagnostic Substances) (2836)
KURA
Kura Oncology, Inc.
Pharmaceutical Preparations (2834)